Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213409699> ?p ?o ?g. }
- W3213409699 endingPage "437" @default.
- W3213409699 startingPage "419" @default.
- W3213409699 abstract "The number of patients with primary cutaneous lymphoma (PCL) relative to other non-Hodgkin lymphomas (NHLs) is small and the number of subtypes large. Although clinical trial guidelines have been published for mycosis fungoides/Sézary syndrome, the most common type of PCL, none exist for the other PCLs. In addition, staging of the PCLs has been evolving based on new data on potential prognostic factors, diagnosis, and assessment methods of both skin and extracutaneous disease and a desire to align the latter with the Lugano guidelines for all NHLs. The International Society for Cutaneous Lymphomas (ISCL), the United States Cutaneous LymphomaConsortium (USCLC), and the Cutaneous Lymphoma Task Force of the European Organization for the Research and Treatment of Cancer (EORTC) now propose updated staging and guidelines for the study design, assessment, endpoints, and response criteria in clinical trials for all the PCLs in alignment with that of the Lugano guidelines. These recommendations provide standardized methodology that should facilitate planning and regulatory approval of new treatments for these lymphomas worldwide, encourage cooperative investigator-initiated trials, and help to assess the comparative efficacy of therapeutic agents tested across sites and studies." @default.
- W3213409699 created "2021-11-22" @default.
- W3213409699 creator A5000675916 @default.
- W3213409699 creator A5001315602 @default.
- W3213409699 creator A5012521997 @default.
- W3213409699 creator A5013307217 @default.
- W3213409699 creator A5015108124 @default.
- W3213409699 creator A5017112762 @default.
- W3213409699 creator A5023456725 @default.
- W3213409699 creator A5032585744 @default.
- W3213409699 creator A5035210370 @default.
- W3213409699 creator A5040812031 @default.
- W3213409699 creator A5041361796 @default.
- W3213409699 creator A5042319853 @default.
- W3213409699 creator A5050290286 @default.
- W3213409699 creator A5051459543 @default.
- W3213409699 creator A5058782928 @default.
- W3213409699 creator A5058825770 @default.
- W3213409699 creator A5064358254 @default.
- W3213409699 creator A5066790760 @default.
- W3213409699 creator A5067107911 @default.
- W3213409699 creator A5067165268 @default.
- W3213409699 creator A5067689004 @default.
- W3213409699 creator A5068807193 @default.
- W3213409699 creator A5069079748 @default.
- W3213409699 creator A5069406522 @default.
- W3213409699 creator A5071547266 @default.
- W3213409699 creator A5072248667 @default.
- W3213409699 creator A5073971261 @default.
- W3213409699 creator A5074536375 @default.
- W3213409699 creator A5075947127 @default.
- W3213409699 creator A5077236629 @default.
- W3213409699 creator A5079170974 @default.
- W3213409699 creator A5082463294 @default.
- W3213409699 creator A5083914569 @default.
- W3213409699 creator A5088820789 @default.
- W3213409699 creator A5090696492 @default.
- W3213409699 date "2022-08-04" @default.
- W3213409699 modified "2023-10-18" @default.
- W3213409699 title "Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC" @default.
- W3213409699 cites W1584810802 @default.
- W3213409699 cites W1644998521 @default.
- W3213409699 cites W1877715550 @default.
- W3213409699 cites W1895474562 @default.
- W3213409699 cites W1972507334 @default.
- W3213409699 cites W1973444240 @default.
- W3213409699 cites W1976541396 @default.
- W3213409699 cites W1984206104 @default.
- W3213409699 cites W1996407449 @default.
- W3213409699 cites W2003734726 @default.
- W3213409699 cites W2015828565 @default.
- W3213409699 cites W2016114542 @default.
- W3213409699 cites W2017004030 @default.
- W3213409699 cites W2020094108 @default.
- W3213409699 cites W2030346687 @default.
- W3213409699 cites W2073100914 @default.
- W3213409699 cites W2076668534 @default.
- W3213409699 cites W2076908917 @default.
- W3213409699 cites W2096160655 @default.
- W3213409699 cites W2096850086 @default.
- W3213409699 cites W2105258029 @default.
- W3213409699 cites W2110957729 @default.
- W3213409699 cites W2112906780 @default.
- W3213409699 cites W2119147717 @default.
- W3213409699 cites W2122538591 @default.
- W3213409699 cites W2124241616 @default.
- W3213409699 cites W2124932867 @default.
- W3213409699 cites W2131900456 @default.
- W3213409699 cites W2133201432 @default.
- W3213409699 cites W2142724147 @default.
- W3213409699 cites W2146854986 @default.
- W3213409699 cites W2160593693 @default.
- W3213409699 cites W2161055005 @default.
- W3213409699 cites W2196324452 @default.
- W3213409699 cites W2260597923 @default.
- W3213409699 cites W2312229826 @default.
- W3213409699 cites W2398070317 @default.
- W3213409699 cites W2473383456 @default.
- W3213409699 cites W2514468425 @default.
- W3213409699 cites W2565883611 @default.
- W3213409699 cites W2592707182 @default.
- W3213409699 cites W2598700764 @default.
- W3213409699 cites W2623658063 @default.
- W3213409699 cites W2790424681 @default.
- W3213409699 cites W2883657584 @default.
- W3213409699 cites W2909144857 @default.
- W3213409699 cites W2909964376 @default.
- W3213409699 cites W2921255655 @default.
- W3213409699 cites W2943404462 @default.
- W3213409699 cites W2980810607 @default.
- W3213409699 cites W2981172334 @default.
- W3213409699 cites W3037580267 @default.
- W3213409699 cites W3049212519 @default.
- W3213409699 doi "https://doi.org/10.1182/blood.2021012057" @default.
- W3213409699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34758074" @default.
- W3213409699 hasPublicationYear "2022" @default.
- W3213409699 type Work @default.
- W3213409699 sameAs 3213409699 @default.